Effectiveness of duloxetine for chemotherapy-induced peripheral neuropathy : a prospective study.

Effectiveness of duloxetine for chemotherapy-induced peripheral neuropathy : a prospective study. - Effectiveness of duloxetine for CIPN : a prospective study.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017096

Enrollment

Registered

2015-04-10

Start date

2013-04-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient with history of cancer

Interventions

Take a duloxetine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chemotherapy-induced peripheral neuropathy

Exclusion criteria

Exclusion criteria: Patients with severe complitcations

Design outcomes

Primary

Measure	Time frame
The response rate of duloxetine for CIPN.	—

Countries

Japan

Contacts

Public ContactKae Okuma

University of Tokyo Hospital Department of radiology

ookumak-rad@h.y-tokyo.ac.jp03-5800-8667

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026